Results 181 to 190 of about 22,974 (229)

Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study. [PDF]

Nat Med
Jelen LA, Lythgoe DJ, Stone JM, Young AH, Mehta MA.   +4 more
europepmc   +1 more source

Willingness to receive medication for opioid use disorder (MOUD): A longitudinal analysis of social network support. [PDF]

Drug Alcohol Depend
Knudsen HK, Rockett M, Oser CB.
europepmc   +1 more source

Exploring strategies to connect formerly incarcerated individuals with community pharmacist-administered injectable naltrexone services. [PDF]

Front Public Health
Chladek JS, Chui MA.
europepmc   +1 more source

Response to Letter by Dr. Verbeck. [PDF]

EClinicalMedicine
Liu L, Li Z, Ye W, Peng P, Wang Y, Wan L, Li J, Zhang M, Wang Y, Liu R, Xu D, Zhang J.   +11 more
europepmc   +1 more source

Telepsychiatry in addiction treatment: Evaluating India's telemedicine guidelines. [PDF]

Indian J Psychiatry
Muhammed JK, Deepali N, Roshan B.
europepmc   +1 more source

Naltrexone: A History and Future Directions.

, 2018
A. Benjamin Srivastava, Mark S. Gold
openalex   +1 more source

Regional blood flow signatures of opioidergic modulation of ketamine in major depressive disorder: a randomised crossover study

Jelen LA, O’Daly O, Zelaya FO, Stone JM, Young AH, Mehta MA.   +5 more
europepmc   +1 more source